#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anti-myelin-associated glycoprotein antibodies positive Sarcoma Leiomyosarcoma recurrent Indolent systemic mastocytosis Acute lymphocytic leukaemia Alveolar rhabdomyosarcoma Anti-myelin-associated glycoprotein associated polyneuropathy Immune thrombocytopenia KBG syndrome Idiopathic intracranial hypertension Nasopharyngeal cancer Infertility female Hypophosphatasia Fontan procedure Thrombocytopenia More trials…

    Learn about Rare Diseases

    KBG syndrome – Trials in Disease Acute respiratory distress syndrome – Trials in Disease Chronic granulomatous disease Advanced systemic mastocytosis Usher’s syndrome – Trials in Disease Hereditary angioedema Toxic epidermal necrolysis – Life with Disease Cholangitis sclerosing Burkitt’s lymphoma – Basic Information Glomerulonephritis membranous – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lonvoguran ZINC Colesevelam Clenbuterol Hydrochloride Budigalimab BENZYLPENICILLIN PROCAINE Co-Trimoxazole RP3 Human Apotransferrin Skb264 Neostigmine Methylsulfate Promethazine Hydrochloride Ficlatuzumab Eptinezumab Censavudine Disitamab Vedotin VERT-002 Polatuzumab Vedotin Tucidinostat Esomeprazole Magnesium More therapies…

    Learn about Your Condition

    Netherton's syndrome Eosinophilic oesophagitis Enteritis Red blood cell abnormality B-cell lymphoma Pneumothorax Schizophrenia Melanoma recurrent Hypoaesthesia Ependymoma malignant Hidradenitis Microvillous inclusion disease Small intestine leiomyosarcoma Peritoneal abscess Colon cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Medulloblastoma recurrent

  • Study of Axitinib and Etoposide for Children and Young Adults with Refractory or Relapsing Medulloblastoma and Ependymoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Ependymoma malignant
    • Medulloblastoma recurrent
    Investigated Drugs:
    • Axitinib
    • Etoposide
    France

  • A study of RVU120 and everolimus for children with recurrent or progressive medulloblastoma

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • 7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
    • Everolimus
    Poland

  • Study on the Safety and Efficacy of AloCelyvir for Children, Adolescents, and Young Adults with Diffuse Intrinsic Pontine Glioma or Medulloblastoma.

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Medulloblastoma recurrent
    • Brain stem glioma
    Investigated Drugs:
    • Allogenic Bone Marrow-Derived Mesenchymal Stem Cells Transduced With Icovir-5, Ex Vivo Expanded
    Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!